Cost-Effectiveness of Genotype-Guided and Dual Antiplatelet Therapies

被引：0
|
作者：
Marciniak, Thomas A. [1 ]
机构：
[1] US FDA, Silver Spring, MD 20993 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2014年 / 161卷 / 05期
关键词：
D O I：
10.7326/L14-5017-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：378 / 378
页数：1
相关论文
共 50 条
  • [31] One-year cost-effectiveness of cytochrome p450 2c19 genotype-guided antiplatelet therapy in patients with acute coronary syndromes in France
    Charland, S. L.
    Agatep, B.
    Spieler, J. F.
    Alvarez, P.
    Malone, D. C.
    Stanek, E. J.
    EUROPEAN HEART JOURNAL, 2011, 32 : 68 - 68
  • [32] Upfront DPYD Genotype-Guided Treatment for Fluoropyrimidine-Based Chemotherapy in Advanced and Metastatic Colorectal Cancer: A Cost-Effectiveness Analysis
    Fariman, Soroush Ahmadi
    Rafsanjani, Zahra Jahangard
    Hasanzad, Mandana
    Niksalehi, Kimia
    Nikfar, Shekoufeh
    VALUE IN HEALTH REGIONAL ISSUES, 2023, 37 : 71 - 80
  • [33] COST-EFFECTIVENESS OF UNIVERSAL OR GENOTYPE DRIVEN USE OF AVAILABLE DUAL ANTIPLATELET STRATEGIES IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Lee, Soyon
    Dhamija, Asha
    Parsons, Katelyn
    King, Matthew
    Kaur, Rajbir
    Roberts, Matthew
    Coleman, Craig
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E483 - E483
  • [34] Genotype-Guided Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Interventions
    Zhou, Y.
    Harada, S.
    Armstead, A. R.
    Coshatt, G. M.
    Sankaranarayanan, A.
    Fuller, J. S.
    Sayers, S. A.
    Blair, C.
    Dillon, C.
    Brott, B. C.
    Alsip, J. A.
    Limdi, N. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 845 - 845
  • [35] Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: Exploring the Role of Genotype-Guided Therapy in Reducing Readmission Rates
    Comanici, Maria
    Raja, Shahzad G.
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 203 : 507 - 508
  • [36] Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic Attack With a Single Small Subcortical Infarction
    Liu, Huihui
    Jing, Jing
    Wang, Anxin
    Xu, Qin
    Meng, Xia
    Li, Hao
    Li, Zixiao
    Wang, Yongjun
    NEUROLOGY, 2023, 100 (16) : E1643 - E1654
  • [37] Cost-Effectiveness Analysis of Genotype-Guided Treatment Allocation in Patients with Alcohol Use Disorders Using Naltrexone or Acamprosate, Using a Modeling Approach
    Sluiter, Reinier L.
    Kievit, Wietske
    van der Wilt, Gert Jan
    Schene, Aart H.
    Teichert, Martina
    Coenen, Marieke J. H.
    Schellekens, Arnt
    EUROPEAN ADDICTION RESEARCH, 2018, 24 (05) : 245 - 254
  • [38] Cost-effectiveness of newer antiplatelet drugs
    Peterson, GM
    Jackson, SL
    ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (20) : 2533 - 2534
  • [39] Cost-effectiveness of biological therapies
    Feetham, Laura
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (05): : 337 - 337
  • [40] COST-EFFECTIVENESS OF A CYP2C19 GENOTYPE-GUIDED ANTIPLATELET STRATEGY IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS: AN ANALYSIS BASED ON THE RANDOMIZED POPULAR GENETICS TRIAL
    Claassens, D.
    Vos, G. J. A.
    Boersma, C.
    Bergmeijer, T. O.
    Hermanides, R. S.
    van t Hof, A. W.
    Van der Harst, P.
    Barbato, E.
    Morisco, C.
    Gin, Tjon Joe R. M.
    Asselbergs, F. W.
    Mosterd, A.
    Herrman, J. P. R.
    Dewilde, W. J.
    Postma, M.
    Deneer, V. H. M.
    Ten Berg, J. M.
    VALUE IN HEALTH, 2020, 23 : S494 - S494
12345